FDA Standards For Levothyroxine Bioequivalence, Substitution May Lead To Adverse Effects
Mon, 09 Oct 2006 07:00 AM EST
... Levothyroxine sodium (LT4), marketed as Unithroid, Synthroid, Levoxyl, and Levothroid, is the principal form of thyroid hormone replacement taken by 13 million Americans. The FDA's current system governing dispensing and substitution of the currently available eight proprietary and generic levothyroxine preparations is confusing for physicians, patients, and pharmacists. [click link for full article] ...
Related Topics
- Lead Poisoning
- Lead
- Levothyroxine
- Blood Lead Levels
- Hepatitis A Vaccine
- Tacrolimus ointment
- Vaccine Identification Standards
- Laboratory Guidelines And Standards
- Poisoning
- Thalidomide
- Levothyroxine Injection
- Vaccine Safety and Adverse Event Reports
- Pimecrolimus Cream 1%
- Yohimbe
- Metoclopramide Oral Solution
- Mammography
- Usher Syndrome: New Insights Lead to Earlier Treatment
- Vaccine Adverse Event Reporting System
- Carcinogens
- Carvedilol

Not Signed In -


